Literature DB >> 29423626

Dangers and Opportunities of Direct-to-Consumer Advertising.

Natasha Parekh1,2, William H Shrank3.   

Abstract

Mesh：

Year:  2018        PMID： 29423626      PMCID： PMC5910355          DOI： 10.1007/s11606-018-4342-9

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  5 in total

1.  Direct-to-Consumer Pharmaceutical Advertising: Therapeutic or Toxic?

Authors:  C Lee Ventola
Journal:  P T       Date:  2011-10

2.  Time to ban direct-to-consumer prescription drug marketing.

Authors:  Kurt C Stange
Journal:  Ann Fam Med       Date:  2007 Mar-Apr       Impact factor: 5.166

3.  Direct-to-Consumer Broadcast Advertisements for Pharmaceuticals: Off-Label Promotion and Adherence to FDA Guidelines.

Authors:  Kristina Klara; Jeanie Kim; Joseph S Ross
Journal:  J Gen Intern Med       Date:  2018-02-26       Impact factor: 5.128

4.  Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial.

Authors:  Richard L Kravitz; Ronald M Epstein; Mitchell D Feldman; Carol E Franz; Rahman Azari; Michael S Wilkes; Ladson Hinton; Peter Franks
Journal:  JAMA       Date:  2005-04-27       Impact factor: 56.272

5.  The Portuguese generic medicines market: a policy analysis.

Authors:  Steven Simoens
Journal:  Pharm Pract (Granada)       Date:  2009-03-15
  5 in total
  4 in total

1.  Consumers' experience with and attitudes toward direct-to-consumer prescription drug promotion: a nationally representative survey.

Authors:  Kathryn J Aikin; Helen W Sullivan; Jennifer Berktold; Karen L Stein; Victoria J Hoverman
Journal:  Health Mark Q       Date:  2021-07-09

2.  Depot buprenorphine injections for opioid use disorder: Patient information needs and preferences.

Authors:  Joanne Neale; Charlotte N E Tompkins; John Strang
Journal:  Drug Alcohol Rev       Date:  2019-05-26

3.  Disease awareness or subtle product placement? Orphan diseases featured in the television series "House, M.D." - a cross-sectional analysis.

Authors:  Konstantin Mechler; Juliane Rausch; William K Mountford; Markus Ries
Journal:  BMC Med Ethics       Date:  2020-03-14       Impact factor: 2.652

4.  Knowledge and Practice of Antibiotic Management and Prudent Prescribing among Polish Medical Doctors.

Authors:  Wojciech Stefan Zgliczyński; Jarosław Bartosiński; Olga Maria Rostkowska
Journal:  Int J Environ Res Public Health       Date:  2022-03-21       Impact factor: 3.390
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.